Multi-Center Clean Air Randomized Controlled Trial in COPD
Multi-Center Clean Air Randomized Controlled Trial in COPD
This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.
The Multi-Center Clean Air Randomized Controlled Trial in COPD (Clean Air) is a multi-center, prospective, randomized, double-blind, sham-controlled trial that will enroll 770 former smokers with COPD over a 4-year period and follow participants at regular intervals for one year. The primary endpoint is respiratory specific quality of life. Secondary endpoints include rate of acute exacerbations, rescue medication use, quality of life, and cost-effectiveness.
Inclusion criteria
To be eligible, subjects must meet all these criteria:
Exclusion criteria
To be eligible, subjects must not meet any one of these criteria:
sehrhar6@jhu.edu(410) 502-3872
Birmingham, Alabama 35233, United States
lunghealth@uabmc.edu205-934-5555
tbina@mednet.ucla.edu310-206-1629
eric-garcia@uiowa.edu319-353-8863
vrodionova@som.umaryland.edu410-328-2835
wlorizi1@jhmi.edu410-510-2449
mmaly1@jhmi.edu410-550-9527
sandra.fetko@tidalhealth.org410-912-6045
aatadika@bidmc.harvard.edu781-964-8163
ccutlip@med.umich.edu734-647-6399
athena.r.fowler.shaw@hitchcock.org603-650-0567
engele2@ccf.org224-235-8363
pamela.marrero@towerhealth.org484-628-8355